Coya Therapeutics, Inc.’s Post

View organization page for Coya Therapeutics, Inc., graphic

3,491 followers

Earlier this month, Coya announced the filing of a patent for a combination of COYA 301 (a low-dose IL2) and GLP-1 that could be a game-changer in the fight against Alzheimer's disease. Learn all about it in this article from InnovationMap: https://lnkd.in/e9FuE3Qw #CoyaTherapeutics #Patent #EndALZ

Houston therapeutics innovator looks into GLP-1 drugs for Alzheimer’s treatment

Houston therapeutics innovator looks into GLP-1 drugs for Alzheimer’s treatment

houston.innovationmap.com

Spencer West

Hacking the brains and Bodies of Lawyers and Execs to Gain Control Over Your Health. - Banish Burnout 🔥🚿 - 20x Your Efficiency 🚀 - Get Stronger and Fitter💪🏼 - Look & Feel 10yrs Younger👶🏼

2mo

Fascinating! Love the multi-targeted approach for #Alzheimers. Let's chat about potential for optimization.

Like
Reply

To view or add a comment, sign in

Explore topics